Compass Therapeutics Inc. (CMPX) — Financial Flexibility Index

Latest as of September 2025: -0.50x

Compass Therapeutics Inc. (CMPX) has a Financial Flexibility Index of -0.50x as of September 2025. Free cash flow of $-10.84 Million (operating CF $-10.85 Million minus capex $7.00K) represents -1% of total liabilities ($21.65 Million). Also explore Compass Therapeutics Inc. (CMPX) net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.50x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-10.84 Million
Operating CF − Capex

Total Liabilities

$21.65 Million
USD

Capital Expenditures

$7.00K
USD

Compass Therapeutics Inc. Financial Flexibility Index (2018–2024)

Historical Financial Flexibility Index trend for Compass Therapeutics Inc. across 7 annual periods. Check CMPX strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Compass Therapeutics Inc. (2018–2024)

Year-by-year free cash flow to debt coverage for Compass Therapeutics Inc.. For the full company profile including market capitalisation, see CMPX market cap overview.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -2.95x $-44.81 Million $-44.85 Million $15.17 Million ▲ +39.3%
2023 -4.87x $-40.59 Million $-40.62 Million $8.34 Million ▼ -158.5%
2022 -1.88x $-33.91 Million $-34.12 Million $18.01 Million ▼ -42.3%
2021 -1.32x $-18.10 Million $-19.67 Million $13.68 Million ▲ +40.7%
2020 -2.23x $-26.70 Million $-26.80 Million $11.97 Million ▼ -962.8%
2019 -0.21x $-31.27 Million $-31.74 Million $148.98 Million ▲ +0.9%
2018 -0.21x $-31.66 Million $-33.68 Million $149.40 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities